These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 24076312)
21. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies. Fujii S Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215 [TBL] [Abstract][Full Text] [Related]
22. Potentiation strategies of dendritic cell-based antitumor vaccines: combinational therapy takes the front seat. Torabi-Rahvar M; Bozorgmehr M; Jeddi-Tehrani M; Zarnani AH Drug Discov Today; 2011 Aug; 16(15-16):733-40. PubMed ID: 21558016 [TBL] [Abstract][Full Text] [Related]
23. DC in multiple myeloma immunotherapy. Turtle CJ; Brown RD; Joshua DE; Hart DN Cytotherapy; 2004; 6(2):128-37. PubMed ID: 15203989 [TBL] [Abstract][Full Text] [Related]
24. Current status and future perspectives of dendritic cell-based cancer immunotherapy. H Yi D; Appel S Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402 [TBL] [Abstract][Full Text] [Related]
25. Dendritic cell vaccines for cancer immunotherapy. Timmerman JM; Levy R Annu Rev Med; 1999; 50():507-29. PubMed ID: 10073291 [TBL] [Abstract][Full Text] [Related]
26. Current issues in delivering DCs for immunotherapy. Barratt-Boyes SM; Figdor CG Cytotherapy; 2004; 6(2):105-10. PubMed ID: 15203986 [TBL] [Abstract][Full Text] [Related]
27. Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells. Breckpot K; Heirman C; Neyns B; Thielemans K J Gene Med; 2004 Nov; 6(11):1175-88. PubMed ID: 15468193 [TBL] [Abstract][Full Text] [Related]
28. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
29. Current issues in dendritic cell cancer immunotherapy. López JA; Hart DN Curr Opin Mol Ther; 2002 Feb; 4(1):54-63. PubMed ID: 11885565 [TBL] [Abstract][Full Text] [Related]
30. Current state and perspectives of dendritic cell vaccination in cancer immunotherapy. Farkas A; Conrad C; Tonel G; Borbenyi Z; Kemeny L; Dobozy A; Nestle FO Skin Pharmacol Physiol; 2006; 19(3):124-31. PubMed ID: 16612139 [TBL] [Abstract][Full Text] [Related]